Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MIGLITOL 25 MG TABLET

Miglitol
$1.7545per EA

Strength

25 mg/1

Manufacturer

Westminster Pharmaceuticals LLC

NDC

69367030301

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

5/21/2025

Active Ingredients

MIGLITOL

Approval Type

Generic (ANDA)

FDA Application

ANDA203965

On Market Since

1/15/2021

Pharmacological Classes

alpha Glucosidase Inhibitors
alpha-Glucosidase Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ACARBOSE 25 MG TABLET
Generic
00054014025•Hikma Pharmaceuticals USA Inc.
$0.1539
per EA
ACARBOSE 25 MG TABLET
Generic
23155014701•Heritage Pharmaceuticals Inc.
$0.1539
per EA
ACARBOSE 25 MG TABLET
Generic
62135045390•Chartwell RX LLC
$0.1539
per EA
ACARBOSE 25 MG TABLET
Generic
64380075806•Strides Pharma Inc.
$0.1539
per EA
ACARBOSE 50 MG TABLET
Generic
00054014125•Hikma Pharmaceuticals USA Inc.
$0.1654
per EA
ACARBOSE 50 MG TABLET
Generic
23155014801•Heritage Pharmaceuticals Inc.
$0.1654
per EA
ACARBOSE 50 MG TABLET
Generic
62135045490•Chartwell RX LLC
$0.1654
per EA
ACARBOSE 50 MG TABLET
Generic
64380075906•Strides Pharma Inc.
$0.1654
per EA
ACARBOSE 25 MG TABLET
Generic
23155014710•Heritage Pharmaceuticals Inc.
$0.1835
per EA
ACARBOSE 50 MG TABLET
Generic
23155014805•Heritage Pharmaceuticals Inc.
$0.1968
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy